H

Hospital Nacional Edgardo Rebagliati Martins | Medical Oncology

Research site
(Unclaimed)
Location
Av. Edgardo Rebagliati 490- Jesus Maria, Lima, Lima, Peru

Site insights

Top conditions

Top treatments

BIIB059
SPD476
Estrogen
Giredestrant
Bosutinib
Bevacizumab
Litifilimab
SKI-606
KW-0761
Trastuzumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 16 total trials

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with end...

Enrolling
Early Breast Cancer
Drug: Endocrine Therapy of Physician's Choice
Drug: Abemaciclib

The primary objective of this study is to evaluate the long-term safety and tolerability of litifilimab in participants with active systemic lupus er...

Invitation-only
Systemic Lupus Erythematosus (SLE)
Drug: Litifilimab-matching placebo
Drug: Litifilimab

Trial sponsors

University of Minnesota (UMN) logo
Biogen logo
C
Grifols logo
J
Kyowa Kirin logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
N
Novartis logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems